html5-img
1 / 10

Postpartum Hemorrhage Treatment Market

Amongst the PPH devices, Uterine balloon tamponade segment accounted for almost half of the overall market in 2015 and it is also poised to grow at the highest CAGR of 6.1% from 2016 to 2022. This is primarily due to the growing number of PPH cases as well as large number of product approvals and increasing positive clinical outcomes of the treatment devices.<br><br>

swati_tamhankar
Télécharger la présentation

Postpartum Hemorrhage Treatment Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Postpartum Hemorrhage (PPH) Devices Market Global Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunity Analysis and Industry Forecast, 2014-2022

  2. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET Global Postpartum Hemorrhage (PPH) Devices Market was valued at $637 million in 2015, and is expected to reach $906 million by 2022 supported by a CAGR of 5.2% during the forecast period 2016 to 2022. Postpartum hemorrhage is the most common form of obstetric hemorrhage and is one of the leading cause of maternal mortality. According to the data revealed by WHO, about one quarter of the maternal deaths occur due to postpartum hemorrhage. Postpartum hemorrhage is classified as primary PPH where blood loss is less than 500 ml and secondary PPH having blood loss more than 500ml. Currently, active management of third labor is practiced for preventing PPH which is administered directly after the child birth. PPH can be treated by first line (non-surgical) methods which involves the adoption of uterotonic drugs such as oxytocin and misoprostol. However, in the absence of drugs, second line intervention devices are adopted such as non-pneumatic anti-shock garment, Uterine balloon tamponade and Uniject prefilled injection systems. Since these devices are effective in stopping the blood flow and stabilize the condition of the patient until substantive care is provided.

  3. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET In Uterine balloon tamponade segment, Foley Catheter is projected to grow fastest with a CAGR of 7.8%, as they are cost effective devices. On the other hand, Bakri balloon tamponade is expected to be the highest revenue generating segment in the PPH devices as they can be easily used in low resource settings and is effective in stopping hemorrhage. Uterine balloon tamponade accounted for a major share in the world PPH devices in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to the rise in the prevalence of PPH cases, increasing awareness among women regarding postpartum hemorrhage and presence of advanced healthcare facilities in developed countries. However, Asia-Pacific is expected to be the fastest growing region throughout the analysis period, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of PPH cases and high rate of anemia among pregnant women in the region. Get more information on this report: https://www.alliedmarketresearch.com/request-sample/1676

  4. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET • Market Dynamics 

  5. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET Top Impacting Factors in Global PPH Market

  6. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET • Key Findings of the Post-Partum Hemorrhage Devices Market • In 2015, Uterine balloon tamponade was the highest revenue-generating segment, and is projected to grow at a CAGR of 6.1% during the forecast period. • In the uterine balloon tamponade devices, Foley catheter is projected to be the fastest growing segment, registering a CAGR of 7.8% from 2016 to 2022. • Asia-Pacific is expected to be the fastest growing region in PPH market by 2022 and is projected to grow at a CAGR of 7.6% • Germany and France accounted for about one-third share of the Europe PPH devices market in 2015. • In 2015, North America was the highest revenue generating region accounting for one-third of the overall market.

  7. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET PPH DEVICES MARKET KEY MARKET SEGMENTS The global PPH devices market is segmented based on product, and geography. • By Product • Non-Pneumatic Anti-Shock Garment • Uniject Prefilled Injection System • Uterine Balloon Tamponade • Foley Catheter • Condom Catheter • Bakri balloon tamponade • BT-Cath balloon • Rusch balloon 

  8. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET • The key players profiled in this report include • Utah Medical Products, Inc., • C. R. Bard, Inc., • Cook Medical, Inc., • Becton, • Dickinson and Company, • Teleflex Incorporated • Bactiguard AB • Program for Appropriate Technology in Health (PATH) • 3RD Stone Design, Inc. • ZoexNiasg • Vitality Medical • Revmedx Inc • Inpress Technologies. Do Purchase and Enquiry about this Report: https://www.alliedmarketresearch.com/purchase-enquiry/1676

  9. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET Contact: Shriram Dighe 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1⟨855⟩550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com

  10. POSTPARTUM HEMORRHAGE (PPH) DEVICES MARKET Thank You! For More Details Visit us at https://www.alliedmarketresearch.com Follow Us On

More Related